Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study.

Rituxan (rituximab) - Roche

Polivy (polatuzumab vedotin-piiq) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42761030

Hong Xu; Lingjie Sun; Songshen Liu; Wei Wang; Xia Zhao; Xue Shi

Sep 20, 2026